4Cyte Pathology is an independent, Australian-owned and operated pathology practice. It was established with a vision to provide accessible, high-quality, and comprehensive pathology services to clinicians and patients across Australia. The company emphasizes accuracy, efficiency, and patient-centric care, utilizing modern technology and a network of laboratories and collection centres. They aim to be a leading provider in the Australian pathology market, known for reliable results and strong support for the medical community.
Serves as the main operational and administrative center, overseeing laboratory services, quality assurance, research & development, and strategic direction for the company's Australian operations.
State-of-the-art laboratory facilities equipped with advanced diagnostic instrumentation and technology. Likely designed for high-throughput sample processing and specialized testing.
A professional, scientific, and service-oriented environment focused on accuracy, collaboration, and continuous improvement in pathology diagnostics. Emphasis on teamwork among pathologists, scientists, technicians, and support staff.
This location is critical for maintaining service quality, coordinating logistics across numerous collection centres, and driving innovation within the company's diagnostic offerings.
4Cyte Pathology's operations are primarily focused within Australia. They have established a significant national presence with numerous laboratories and collection centres across New South Wales, Victoria, Queensland, Western Australia, Tasmania and South Australia. While their direct operational footprint is Australian, they adhere to international standards of quality and best practice in pathology.
112-118 Talavera Road
Macquarie Park
NSW
Australia
Address: Various collection centres and laboratories, e.g., Level 1, 320 Victoria Parade, East Melbourne VIC 3002 (Main VIC Laboratory)
To deliver timely and accurate diagnostic results to support healthcare providers and patient care throughout Victoria and surrounding regions.
Address: Various collection centres and laboratories, e.g., 140 Melbourne Street, South Brisbane QLD 4101 (Main QLD Laboratory)
To expand access to quality pathology services in Queensland, ensuring efficient turnaround times and reliable diagnostics for patients and doctors in the state.
Address: Various collection centres and laboratories, e.g., Unit 1, 310 Selby Street North, Osborne Park WA 6017 (Main WA Laboratory)
To cater to the specific pathology requirements of Western Australia, offering a broad spectrum of tests and fostering local healthcare partnerships.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 4Cyte Pathology' leadership includes:
4Cyte Pathology has been backed by several prominent investors over the years, including:
As a privately held company, 4Cyte Pathology does not frequently publicize executive movements. Any significant changes are typically communicated through internal channels or specific industry announcements. No major executive hires or exits have been widely reported in the last 12 months.
Discover the tools 4Cyte Pathology uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
4Cyte Pathology commonly uses the email format of [first_initial][last] or [first].[last] followed by @4cyte.com.au. This is a standard convention for many Australian companies.
[first_initial][last]@4cyte.com.au
Format
jdoe@4cyte.com.au
Example
80%
Success rate
AMA WA • May 9, 2024
The Australian Medical Association of Western Australia (AMA WA) has announced a partnership with 4Cyte Pathology to provide free flu vaccinations for its members and their practice staff across WA. This initiative aims to enhance protection for healthcare workers during the flu season....more
Tasmanian Government Health • November 16, 2023
4Cyte Pathology has commenced providing community pathology services in Tasmania, marking its expansion into the state. This includes opening collection centres and offering bulk-billed testing to improve access for Tasmanians....more
The West Australian • July 28, 2022
4Cyte Pathology is expanding its presence in Western Australia with a new laboratory in Osborne Park, Perth. This move is part of the company's strategy to increase its service capacity and reach in the state....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 4Cyte Pathology, are just a search away.